SHAREHOLDERS' EQUITY - Narrative (Details) |
3 Months Ended | 9 Months Ended | 82 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 18, 2021 |
Feb. 04, 2020
USD ($)
sales_agent
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
May 21, 2024
USD ($)
|
May 20, 2024
USD ($)
|
Aug. 02, 2022
USD ($)
|
Aug. 01, 2022
USD ($)
|
Aug. 31, 2021
USD ($)
|
Jul. 28, 2021
USD ($)
|
May 26, 2021
USD ($)
|
Mar. 04, 2019
USD ($)
|
|
| Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
| Repurchase authorized amount | $ 20,000,000 | $ 20,000,000 | |||||||||||||
| Restricted Stock | 2010 Plan | |||||||||||||||
| Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
| Right to grant period | 10 years | ||||||||||||||
| Equity ATM Program | |||||||||||||||
| Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
| Maximum consideration threshold | $ 100,000,000.0 | $ 1,000,000,000 | $ 650,000,000 | $ 650,000,000.0 | $ 250,000,000.0 | $ 250,000,000.0 | $ 50,000,000.0 | ||||||||
| Number of additional sales agents | sales_agent | 2 | ||||||||||||||
| Gross sales commission percentage | 2.00% | 1.50% | |||||||||||||
| Number of shares sold (in shares) | shares | 2,490,000 | 2,364,147 | 6,291,892 | 4,702,227 | 39,333,069 | ||||||||||
| Weighted average price per share (in usd per share) | $ / shares | $ 21.11 | $ 22.68 | $ 21.39 | $ 23.93 | $ 21.47 | ||||||||||
| Gross proceeds received | $ 52,553,000 | $ 53,620,000 | $ 134,582,000 | $ 112,540,000 | $ 844,600,000 | ||||||||||
| Net proceeds received | 51,765,000 | $ 52,915,000 | 132,661,000 | $ 110,951,000 | 831,700,000 | ||||||||||
| Available under the equity ATM program | $ 155,400,000 | $ 155,400,000 | $ 155,400,000 | ||||||||||||